Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 14 of 95
Health
U.S. reaches $1.74 billion deal with Moderna for its Omicron-specific vaccine
By
Zeke Miller
and
The Associated Press
July 29, 2022
Commentary
Here’s what the pandemic really looks like in America’s medical deserts
By
Daniel Greenleaf
July 28, 2022
Health
Fauci calls BA.5 a ‘moving target’ that may subside by the time Omicron boosters are ready. Scientists are pushing for a universal COVID vaccine instead
By
Grady McGregor
July 28, 2022
Commentary
A global effort to stop the spread of COVID-19 in Africa is underway–and it starts with health care workers
By
Adar Poonawalla
July 27, 2022
Tech
Facebook considers relaxing COVID-19 misinformation policies
By
Chris Morris
July 26, 2022
Health
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
By
Grady McGregor
July 26, 2022
Health
Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut
By
Chloe Taylor
July 25, 2022
The Bill & Melinda Gates Foundation partly funded an Omicron variant study with a surprising conclusion about boosters
By
Christine Mui
July 21, 2022
Health
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
By
Grady McGregor
July 20, 2022
Health
CDC endorses Novavax COVID shot for adults, adding to the number of vaccine options
By
Lauran Neergaard
and
The Associated Press
July 19, 2022
Commentary
New viral threats are moving fast. Here’s how we can move faster
By
Gavin Cloherty
July 18, 2022
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By
Grady McGregor
July 14, 2022
Commentary
COVID finally got me. Will it come for you?
By
Carolyn Barber
July 12, 2022
Health
An Omicron vaccine is coming. Should you wait for it—or get your next booster now amid BA.5’s surge?
By
Nicholas Gordon
July 12, 2022
Health
New Omicron subvariants are causing COVID rates to increase. These are the states where it’s most contagious right now
By
Andrew Marquardt
July 11, 2022
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez